NASDAQ:FBIO Fortress Biotech Q2 2025 Earnings Report $2.03 -0.04 (-1.93%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$2.05 +0.02 (+0.94%) As of 10/2/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Fortress Biotech EPS ResultsActual EPS-$0.46Consensus EPS -$0.31Beat/MissMissed by -$0.15One Year Ago EPSN/AFortress Biotech Revenue ResultsActual Revenue$16.41 millionExpected Revenue$14.53 millionBeat/MissBeat by +$1.88 millionYoY Revenue GrowthN/AFortress Biotech Announcement DetailsQuarterQ2 2025Date8/14/2025TimeBefore Market OpensConference Call DateTuesday, August 12, 2025Conference Call Time4:00PM ETUpcoming EarningsFortress Biotech's Q3 2026 earnings is estimated for Monday, November 16, 2026, based on past reporting schedules, with a conference call scheduled on Wednesday, November 11, 2026 at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Fortress Biotech Earnings HeadlinesEli Lilly and Company (NYSE:LLY) vs. Fortress Biotech (NASDAQ:FBIO) Head-To-Head SurveyOctober 2 at 4:15 AM | americanbankingnews.comJourney Medical Corporation to Participate in September 2026 Investor ConferencesSeptember 8, 2026 | globenewswire.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.October 3 at 1:00 AM | Banyan Hill Publishing (Ad)Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | globenewswire.comFortress Biotech (FBIO) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | finance.yahoo.comFortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsAugust 13, 2026 | globenewswire.comSee More Fortress Biotech Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Fortress Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Fortress Biotech and other key companies, straight to your email. Email Address About Fortress BiotechFortress Biotech (NASDAQ:FBIO) is a biopharmaceutical company focused on developing and commercializing medicines for serious and underserved medical conditions. The company operates through a network of subsidiaries and strategic partners, supporting drug discovery, clinical development, regulatory activities and commercialization. Its research and development activities span areas including oncology, immunology, dermatology, central nervous system disorders and rare diseases. Fortress has used its platform to establish or support subsidiary companies developing therapeutic candidates and commercial products, with programs ranging from early-stage research through late-stage clinical development and marketed medicines. Founded in 2014, Fortress Biotech serves patients primarily through the United States healthcare market while pursuing opportunities to advance its therapies internationally through licensing and commercial partnerships. Its business model emphasizes building specialized biotechnology companies around individual drug-development programs and therapeutic areas.View Fortress Biotech ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/28 - 10/02Time to Nibble on MCD Stock After it Enters Oversold Territory?McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal UpsideMicron’s Earnings Reveal Why the AI Memory Boom May Last LongerAnthropic's IPO Could Put Amazon's and Alphabet's Paper Profits to the TestBoeing’s Fighter Victory Opens the Door to Decades of Defense RevenueCorning and AT&T's $3 Billion Fiber Deal Reveals Where AI Spending Goes Next Upcoming Earnings PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
